The Centers for Disease Control and Prevention is investigating an incident in which a teenager from Michigan died just days after receiving his second COVID-19 shot.
Jacob Clynick, 13, died in his sleep three days after getting his second shot of Pfizer‘s coronavirus vaccine in mid-June, prompting authorities to investigate his death.
“CDC is aware of a 13-year-old boy in Michigan who died after receiving a COVID-19 vaccination. This case is currently under investigation and until the investigation is complete, it is premature to assign a specific cause of death,” said Jade Fulce, public affairs specialist for the CDC, in an email to the Washington Examiner. “When a serious adverse event, like death, is reported to the Vaccine Adverse Event Reporting System (VAERS) after COVID-19 vaccination, CDC requests and reviews all medical records associated with the case, including death certificates, and autopsy reports. The determination of the cause of death is done by the certifying official who completes the death certificate or the pathologist who conducts the autopsy. VAERS is not designed to determine if the vaccine caused the reported adverse event. While some reported adverse events may be caused by vaccination, others are not and may have occurred coincidentally.”
Tami Burages, his aunt, said Clynick was healthy and had no known underlying medical conditions, according to the Detroit Free Press.
BIDEN PLEDGES VACCINATION CAMPAIGN WILL GO ‘DOOR TO DOOR’ AFTER FALLING SHORT OF JULY FOURTH GOAL
Ever since a CDC panel recommended the Pfizer vaccine for children ages 12-15 on May 12, vaccine rates have increased among that population. More than 9 million people in the United States between the ages of 12-18 have received at least one dose of the COVID-19 vaccine, and nearly 7 million have received both doses, according to the CDC.
Pfizer’s is not the only coronavirus vaccine linked to some possible side effects.
A handful of recipients of Johnson & Johnson’s single-shot COVID-19 vaccine developed rare blood clots after their inoculations, prompting federal regulators to enact a one-week pause on its administration that was lifted on April 23. However, the Food and Drug Administration advised the company to add a warning label for women under 50.
CLICK HERE TO READ MORE FROM THE WASHINGTON EXAMINER
Representatives for Pfizer did not immediately respond to the Washington Examiner’s request for comment.